WallStreetZenWallStreetZen

NASDAQ: CPRT
Copart Inc Stock Forecast, Predictions & Price Target

Analyst price target for CPRT

Based on 1 analyst offering 12 month price targets for Copart Inc.
Min Forecast
$51.00-4.71%
Avg Forecast
$51.00-4.71%
Max Forecast
$51.00-4.71%

Should I buy or sell CPRT stock?

Based on 1 analyst offering ratings for Copart Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CPRT stock forecasts and price targets.

CPRT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-08
lockedlocked$00.00+00.00%2023-12-04

1 of 1

Forecast return on equity

Is CPRT forecast to generate an efficient return?

Forecast return on assets

Is CPRT forecast to generate an efficient return on assets?

CPRT revenue forecast

What is CPRT's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$4.2B+1.64%
Avg 2 year Forecast
$4.7B+12.43%
Avg 3 year Forecast
$5.1B+22.16%
CPRT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CPRT revenue growth forecast

How is CPRT forecast to perform vs Specialty Business Services companies and vs the US market?
Company
5.91%
Industry
4.48%
Market
9.38%
CPRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CPRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CPRT vs Specialty Business Service Stocks

TickerPricePrice TargetUp/downsideConsensus
CPRT$53.52$51.00-4.71%Hold
CTAS$696.07$724.60+4.10%Strong Buy
GPN$103.24$153.31+48.50%Buy
TRI$172.72$172.88+0.09%Buy
RELX$44.16N/AN/A

Copart Stock Forecast FAQ

Is Copart Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CPRT) stock is to Hold CPRT stock.

Out of 1 analyst, 0 (0%) are recommending CPRT as a Strong Buy, 0 (0%) are recommending CPRT as a Buy, 1 (100%) are recommending CPRT as a Hold, 0 (0%) are recommending CPRT as a Sell, and 0 (0%) are recommending CPRT as a Strong Sell.

If you're new to stock investing, here's how to buy Copart stock.

What is CPRT's revenue growth forecast for 2024-2026?

(NASDAQ: CPRT) Copart's forecast annual revenue growth rate of 5.91% is forecast to beat the US Specialty Business Services industry's average forecast revenue growth rate of 4.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.38%.

Copart's revenue in 2024 is $4,165,415,000.On average, 3 Wall Street analysts forecast CPRT's revenue for 2024 to be $4,074,162,119,415, with the lowest CPRT revenue forecast at $4,033,518,517,855, and the highest CPRT revenue forecast at $4,101,379,744,818. On average, 3 Wall Street analysts forecast CPRT's revenue for 2025 to be $4,506,676,400,059, with the lowest CPRT revenue forecast at $4,358,544,156,244, and the highest CPRT revenue forecast at $4,642,037,030,088.

In 2026, CPRT is forecast to generate $4,896,776,451,554 in revenue, with the lowest revenue forecast at $4,896,776,451,554 and the highest revenue forecast at $4,896,776,451,554.

What is CPRT's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: CPRT) forecast ROA is N/A, which is lower than the forecast US Specialty Business Services industry average of N/A.

What is CPRT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CPRT price target, the average CPRT price target is $51.00, with the highest CPRT stock price forecast at $51.00 and the lowest CPRT stock price forecast at $51.00.

The Wall Street analyst predicted that Copart's share price could fall to $51.00 by Dec 4, 2024. The average Copart stock price prediction forecasts a potential downside of 4.71% from the current CPRT share price of $53.52.

What is CPRT's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: CPRT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.